Live Breaking News & Updates on Small business research loan
Stay updated with breaking news from Small business research loan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Greensboro medical device company is poised to launch a biopsy platform that includes a needle with a proprietary and patented design that will offer physicians a more thorough, accurate and efficient tissue sampling and retrieval method.
CytexOrtho, a pre-clinical stage medical device company working to advance orthopaedic treatment options for cartilage repair, has won the inaugural OrthoPitch Technology Competition during the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in San Francisco.
The road to the commercial contraceptive market is a “constant battle,” admits Michael O’Rand, Ph.D. For nearly a decade, O’Rand’s company Eppin Pharma Inc. has been traveling the long and expensive path of developing a drug that has the potential to completely transform family planning: a male birth control pill. “It costs hundreds of millions of dollars
Scott Lyman believes his small biopharmaceutical startup company in Raleigh has devised a more patient-friendly, rapid-acting and cost-effective way to ensure patients have access to epinephrine during emergencies.
/PRNewswire/ -- BMI OrganBank, a developer of organ perfusion systems, announced today that it has been approved for a Small Business Research Loan from the...
Dignify Therapeutics, a pharmaceutical and medical device development company in Research Triangle Park focused on restoring bowel and bladder control for elderly and neurologically impaired people, has added a new compound to its product pipeline.
Durham-based 410 Medical, a medical device company developing new technologies for emergency and critical care, has completed its $7.5 million Series B venture capital financing. Here are the details.
Dignify Therapeutics, a pharmaceutical and medical device development company in Research Triangle Park, has received a major federal award to advance its main drug candidate for treating bladder and bowel dysfunction.
Durham pharmaceutical company Eppin Pharma has secured an investment of up to $800,000 from the Male Contraceptive Initiative, a national nonprofit also based in Durham, to help initiate clinical trials for its male birth-control pill.
Durham-based 410 Medical has received up to nearly $2 million in U.S. military funding to develop two new versions of LifeFlow, its medical device for treating life-threatening low blood pressure, shock and sepsis in critically ill patients.